Kymera Therapeutics, Inc.

Direct answer

Kymera Therapeutics, Inc. is publicly traded on NASDAQ under the ticker KYMR.

Kymera Therapeutics, Inc. is a biopharmaceutical company dedicated to discovering and developing pioneering small molecule therapeutics. These treatments operate by harnessing the body's inherent protein degradation system to selectively eliminate disease-causing proteins. The company's pipeline features several programs, including the IRAK4 program, currently in Phase I clinical trials, which targets various...

Can you invest in Kymera Therapeutics, Inc.?

Yes. Kymera Therapeutics, Inc. is publicly traded on NASDAQ under the ticker KYMR.

View deeper analysis

View detailed research on MarketSnap, including financials, valuation tools, and analyst context.

Open research for Kymera Therapeutics, Inc.

Detailed equity research is provided by MarketSnap.